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Pulmonary hypertension associated with
Whipple disease
To the Editor:
Whipple disease is a rare multi-systemic disorder caused by Thropheryma whipplei, a Gram-positive bacillus.
Gastrointestinal manifestations are the most frequent, but many other organs may be involved [1, 2].
Pulmonary hypertension (PH) associated with Whipple disease is extremely rare, and only a few isolated
cases have been reported. We present two patients with PH-Whipple disease with a positive vasodilator test
and excellent response to antibiotic therapy.
Patient 1
A 72-year-old Caucasian male with an 8-month history of intermittent abdominal pain and diarrhoea
presented with dyspnoea on exertion that had progressed in the last 4 months (functional class III) and
two-pillow orthopnoea to keep his head at 30u. He reported weight loss of 6 kg during the preceding
8 months. A colonoscopy performed 15 days before showed only nonspecific inflammation. Past medical
history included mild chronic obstructive pulmonary disease treated with ipratropium. Physical
examination revealed hypotension (systolic arterial pressure 90 mmHg) and bibasilar rales but not lower
leg oedema. Laboratory data showed haemoglobin of 94 g?L-1 and albumin of 19 g?L-1. Antinuclear
antibodies, rheumatoid factor and a HIV test were negative. A chest computed tomography (CT) with
embolism protocol demonstrated bilateral pleural and pericardial effusions and mediastinal adenopathy. No
emboli were found in the pulmonary arteries. Abdominal CT showed mild ascites and multiple small lymph
nodes. Gastroduodenoscopy demonstrated diffuse inflammation in the duodenum. Small bowel biopsies
showed typical periodic acid–Schiff (PAS)-positive diastase-resistant histiocytes. Several days later PCR
confirmed the presence of T. whipplei. Transthoracic echocardiography showed normal left cavities with a
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dilated right ventricle (55 mm). The velocity of the tricuspid jet was 3.68 m?s-1 with an estimated systolic
pulmonary artery pressure (sPAP) of 64 mmHg. A ventilation/perfusion scan excluded thromboembolic
disease. Right heart catheterisation confirmed the diagnosis of PH (table 1). A vasodilator test with
epoprostenol revealed a positive response with a 12 mmHg decrease of mean pulmonary artery pressure
(mPAP) and ,1 L?m-1?m-2 increase of cardiac index. A 4-week course of 2 g ceftriaxone per 24 h was
started followed by trimethoprim/sulfamethoxazole 160/800 mg. 2 months later the patient was much better
(functional class I) with N-terminal pro-brain natriuretic peptide (NT-proBNP) 288 pg?mL-1. An
echocardiogram was performed with near normal values (right ventricle 36 mm) and minimal tricuspid
insufficiency. After 10 months of treatment all symptoms resolved and a new echocardiogram was normal.
Patient 2
A 66-year-old Caucasian male doctor was admitted with worsening dyspnoea and near-syncope. He had
been a mild smoker 20 years previously and showed moderate airflow obstruction (forced expiratory
volume in 1 s 52%), which was treated with tiotropium. In the previous year he had received several courses
of non-steroidal anti-inflammatory drugs and prednisone because of spinal and polyarticular pain.
2 months before admission he had complained of diarrhoea but a colonoscopy showed no abnormalities.
Physical examination revealed a sPAP of 95 mmHg and bilateral pretibial oedema. A CT scan showed
pulmonary artery dilatation with no evidence of emboli. A ventilation/perfusion scan ruled out pulmonary
embolism. Laboratory data showed anaemia and increased levels of NT-proBNP (5640 pg?mL-1). Tests for
antinuclear antibodies and HIV serology were negative. Gastroscopy revealed diffusely erithematous antral
mucosa. Duodenal biopsies and PCR for T. whipplei confirmed the diagnosis of Whipple disease.
Transthoracic echocardiography showed a dilated right ventricle (53 mm) with an estimated sPAP of
112 mmHg. Magnetic resonance imaging revealed a right ventricle of 87x53 mm with an ejection fraction
of 53% and normal left cavities (fig. 1). Right heart catheterisation confirmed PH (table 1), with a positive
response to epoprostenol (mPAP decrease of 13 mmHg, cardiac index increase .2 L?m-1?m-2). Because
biopsy results were not known at the time of catheterisation, the patient was initially treated with
amlodipine 20 mg?day-1. 7 days later he was admitted to the hospital with dyspnoea at rest, sPAP 85 mmHg
TABLE 1 Haemodynamic studies of the two patients pre- and post-vasodilator testing
dPAP
mmHg
mPAP
mmHg
sPAP
mmHg
PCWP#
mmHg
CI
L?m-1?m-2
PVR
Wood unit
Pre-vasodilator test
Case 1 29 34 47 10 2.05 6.7
Case 2 33 52 87 14 2.3 7.91
Post-vasodilator test
Case 1 20 25 34 9 3.1 3.9
Case 2 23 39 65 12 3.8 3.1
dPAP: diastolic pulmonary arterial pressure; mPAP: mean pulmonary artery pressure; sPAP systolic
pulmonary artery pressure; PCWP: pulmonary capillary wedge pressure; CI: cardiac index; PVR pulmonary
vascular resistance. #: both patients showed PCWP within normal limits.
FIGURE 1 Magnetic resonance image
from patient 2 showing marked
enlargement of right cardiac chambers.
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and oxygen saturation 89%. Chest radiography showed bilateral pleural effusion. Owing to the high
suspicion of PH-Whipple disease, 2 g of ceftriaxone every 24 h was started. After 10 days of treatment,
with confirmed diagnosis, a significant improvement was noted. Oxygen saturation at rest was 96%.
Echocardiography demonstrated a reduction in sPAP (estimated 61 mmHg). Trimethoprim/sulfamethox-
azole 160/800 mg was started after 2 weeks of ceftriaxone. Amlodipine was discontinued 3 months later.
6 months after starting antibiotics the patient was in functional class I, with an estimated sPAP of
41 mmHg and NT-proBNP of 244 pg?mL-1.
Discussion
The first description of Whipple disease was reported in 1907 by George Whipple. The causative agent of
this disease is T. whipplei, a Gram-positive Actinobacterium. In 1991, a PCR assay was developed providing
an excellent tool for the diagnosis of the disease [3]. Infection occurs via the gastrointestinal route with
intensive macrophage recruitment and activation. It predominantly occurs in males (8:1 male-to-female
ratio). As in other inflammatory diseases, genetic susceptibility probably plays an important role. A defect in
cellular immune response may predispose to infection and might explain the rarity of the disorder despite
the ubiquitous presence of T. whipplei, but the immunological defect is, in some way, probably specific to
this pathogen since other infections do not occur more frequently. Humoral response does not appear to be
affected, with normal levels of IgG and IgM. Moreover, the impaired immunity is probably also increased by
the presence of T. whipplei. Macrophages from patients with Whipple disease have a lower ability to
phagocytosis and expression of CD11b in circulating cells, a receptor that facilitates cell adhesion, is very
low [4]. One of the main features is decreased production of interleukin (IL)-12, a typical cytokine of
activated macrophages that is key in T-helper 1 differentiation and, therefore, interferon-c production [5].
There is also reduced secretion of IL-1, IL-6 and IL-10, but the production of transforming growth factor
(TGF)-b is increased. The TGF-b pathway has been shown to be a key role in the development of
pulmonary arterial hypertension. Apoptosis of macrophages is another critical event in the pathogenesis of
Whipple disease, which seems to be induced by intracellular T. whipplei and may explain the dissemination
of the pathogen [6]. These inflammatory changes in the pulmonary arteries and venules are perhaps the
basis of the increased pulmonary vascular pressure.
Symptoms are nonspecific but the most typical are arthralgia, diarrhoea, abdominal pain and weight loss,
but cardiac and central nervous system involvement may occur. Diagnosis is based on duodenal biopsy with
the presence of PAS-positive histiocytes and direct testing for bacterial DNA by PCR. Current treatment
consists of ceftriaxone for 2–4 weeks followed by trimethoprim/sulfametoxazole for at least 1 year.
Pulmonary involvement by Whipple disease is not well defined but perhaps is not uncommon, while PH-
Whipple disease is extremely rare. The two cases that were first reported were secondary to aortic
insufficiency, probably related to endocarditis caused by T. whipplei [7, 8]. Another five cases have been
reported [9–13], two of them with haemodynamic studies and only one with vasodilator testing. Pulmonary
capillary wedge pressure was normal in our patients but nevertheless we cannot exclude capillary venous
involvement. The underlying pathogenic mechanism of PH in Whipple disease has not been clearly
established but complete resolution with antibiotics, as presented in our cases, is the strongest evidence for a
causal relationship. Pleural biopsies from one patient with confirmed PH-Whipple disease demonstrated
subpleural pulmonary arteries with partial luminal obliteration by PAS-positive macrophages and fibrinoid
debris [11]. This inflammatory nature of PH-Whipple disease may explain the dramatic response of PH to
antibiotic therapy. It is noteworthy that a Jarisch–Herxheimer reaction has been described in one patient,
probably related to the strong effect of antibiotics [10]. Another important aspect is the positive response to
vasodilator testing in our patients and in the other cases reported previously, as well as the poor results with
calcium blockers. One of our patients was initially treated with amlodipine according to the results of
vasodilator testing but no significant response was achieved. Similar results were seen in the patient
reported by NAJM et al. [12] treated with sildenafil and nifedipine, with minimal early improvement but
severe worsening a few months later. We did not perform right heart catheterisation during follow-up due
to the excellent outcome of our patients, although it would be very interesting to know if they had
normalised haemodynamic values. In both cases, the serial echocardiograms showed progressive
improvement and were virtually normal after 10 and 6 months of antibiotic treatment, respectively.
In conclusion, we reported two patients with PH-Whipple disease, an extremely rare association, both with
positive vasodilator testing and complete resolution of PH shortly after antibiotic treatment. These results
suggest an inflammatory nature of PH and add evidence to causal relationships with Whipple disease.
Vasodilators seem to have little efficacy.
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